

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding and managing... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1640/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1640" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding and managing chronic constipation" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding and managing chronic constipation.">
            <meta name="og:description" content="Read the latest article version by David O. Prichard, Adil E. Bharucha, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17359">
            <meta name="article-id" content="15900">
            <meta name="dc.title" content="Recent advances in understanding and managing chronic constipation">
            <meta name="dc.description" content="Constipation, a condition characterized by heterogeneous symptoms, is common in Western society. It is associated with reduced physical health, mental health, and social functioning. Because constipation is rarely due to a life-threatening disease (for example, colon cancer), current guidelines recommend empiric therapy. Limited surveys suggest that fewer than half of treated individuals are satisfied with treatment, perhaps because the efficacy of drugs is limited, they are associated with undesirable side effects, or they may not target the underlying pathophysiology. For example, although a substantial proportion of constipated patients have a defecatory disorder that is more appropriately treated with pelvic floor biofeedback therapy than with laxatives, virtually no pharmacological trials formally assessed for anorectal dysfunction. Recent advances in investigational tools have improved our understanding of the physiology and pathophysiology of colonic and defecatory functions. In particular, colonic and anorectal high-resolution manometry are now available. High-resolution anorectal manometry, which is increasingly used in clinical practice, at least in the United States, provides a refined assessment of anorectal pressures and may uncover structural abnormalities. Advances in our understanding of colonic molecular physiology have led to the development of new therapeutic agents (such as secretagogues, pro-kinetics, inhibitors of bile acid transporters and ion exchangers). However, because clinical trials compare these newer agents with placebo, their efficacy relative to traditional laxatives is unknown. This article reviews these physiologic, diagnostic, and therapeutic advances and focuses particularly on newer therapeutic agents.">
            <meta name="dc.subject" content="Constipation, diagnosis, management, lubiprostone, linaclotide, plecanatide, prucalopride, velusetrag, elobixibat, NGM282, tenapanor">
            <meta name="dc.creator" content="Prichard, David O.">
            <meta name="dc.creator" content="Bharucha, Adil E.">
            <meta name="dc.date" content="2018/10/15">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.15900.1">
            <meta name="dc.source" content="F1000Research 2018 7:1640">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Constipation">
            <meta name="prism.keyword" content="diagnosis">
            <meta name="prism.keyword" content="management">
            <meta name="prism.keyword" content="lubiprostone">
            <meta name="prism.keyword" content="linaclotide">
            <meta name="prism.keyword" content="plecanatide">
            <meta name="prism.keyword" content="prucalopride">
            <meta name="prism.keyword" content="velusetrag">
            <meta name="prism.keyword" content="elobixibat">
            <meta name="prism.keyword" content="NGM282">
            <meta name="prism.keyword" content="tenapanor">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/10/15">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1640">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.15900.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1640">
            <meta name="citation_title" content="Recent advances in understanding and managing chronic constipation">
            <meta name="citation_abstract" content="Constipation, a condition characterized by heterogeneous symptoms, is common in Western society. It is associated with reduced physical health, mental health, and social functioning. Because constipation is rarely due to a life-threatening disease (for example, colon cancer), current guidelines recommend empiric therapy. Limited surveys suggest that fewer than half of treated individuals are satisfied with treatment, perhaps because the efficacy of drugs is limited, they are associated with undesirable side effects, or they may not target the underlying pathophysiology. For example, although a substantial proportion of constipated patients have a defecatory disorder that is more appropriately treated with pelvic floor biofeedback therapy than with laxatives, virtually no pharmacological trials formally assessed for anorectal dysfunction. Recent advances in investigational tools have improved our understanding of the physiology and pathophysiology of colonic and defecatory functions. In particular, colonic and anorectal high-resolution manometry are now available. High-resolution anorectal manometry, which is increasingly used in clinical practice, at least in the United States, provides a refined assessment of anorectal pressures and may uncover structural abnormalities. Advances in our understanding of colonic molecular physiology have led to the development of new therapeutic agents (such as secretagogues, pro-kinetics, inhibitors of bile acid transporters and ion exchangers). However, because clinical trials compare these newer agents with placebo, their efficacy relative to traditional laxatives is unknown. This article reviews these physiologic, diagnostic, and therapeutic advances and focuses particularly on newer therapeutic agents.">
            <meta name="citation_description" content="Constipation, a condition characterized by heterogeneous symptoms, is common in Western society. It is associated with reduced physical health, mental health, and social functioning. Because constipation is rarely due to a life-threatening disease (for example, colon cancer), current guidelines recommend empiric therapy. Limited surveys suggest that fewer than half of treated individuals are satisfied with treatment, perhaps because the efficacy of drugs is limited, they are associated with undesirable side effects, or they may not target the underlying pathophysiology. For example, although a substantial proportion of constipated patients have a defecatory disorder that is more appropriately treated with pelvic floor biofeedback therapy than with laxatives, virtually no pharmacological trials formally assessed for anorectal dysfunction. Recent advances in investigational tools have improved our understanding of the physiology and pathophysiology of colonic and defecatory functions. In particular, colonic and anorectal high-resolution manometry are now available. High-resolution anorectal manometry, which is increasingly used in clinical practice, at least in the United States, provides a refined assessment of anorectal pressures and may uncover structural abnormalities. Advances in our understanding of colonic molecular physiology have led to the development of new therapeutic agents (such as secretagogues, pro-kinetics, inhibitors of bile acid transporters and ion exchangers). However, because clinical trials compare these newer agents with placebo, their efficacy relative to traditional laxatives is unknown. This article reviews these physiologic, diagnostic, and therapeutic advances and focuses particularly on newer therapeutic agents.">
            <meta name="citation_keywords" content="Constipation, diagnosis, management, lubiprostone, linaclotide, plecanatide, prucalopride, velusetrag, elobixibat, NGM282, tenapanor">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="David O. Prichard">
            <meta name="citation_author_institution" content="Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA">
            <meta name="citation_author" content="Adil E. Bharucha">
            <meta name="citation_author_institution" content="Clinical Enteric Neuroscience Translational and Epidemiological Research Program and Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA">
            <meta name="citation_publication_date" content="2018/10/15">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1640">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.15900.1">
            <meta name="citation_firstpage" content="1640">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1640/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1640.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17359 /> <input type=hidden id=articleId name=articleId value=15900 /> <input type=hidden id=xmlUrl value="/articles/7-1640/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1640-v1.xml"> <input type=hidden id=article_uuid value=2b847b95-548b-4c51-85bd-c9dd15c0f903 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding and managing chronic constipation"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.15900.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.15900.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1640"
  },
  "headline": "Recent advances in understanding and managing chronic constipation",
  "datePublished": "2018-10-15T10:20:52",
  "dateModified": "2018-10-15T10:20:52",
  "author": [
    {
      "@type": "Person",
      "name": "David O. Prichard"
    },    {
      "@type": "Person",
      "name": "Adil E. Bharucha"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Constipation, a condition characterized by heterogeneous symptoms, is common in Western society. It is associated with reduced physical health, mental health, and social functioning. Because constipation is rarely due to a life-threatening disease (for example, colon cancer), current guidelines recommend empiric therapy. Limited surveys suggest that fewer than half of treated individuals are satisfied with treatment, perhaps because the efficacy of drugs is limited, they are associated with undesirable side effects, or they may not target the underlying pathophysiology. For example, although a substantial proportion of constipated patients have a defecatory disorder that is more appropriately treated with pelvic floor biofeedback therapy than with laxatives, virtually no pharmacological trials formally assessed for anorectal dysfunction. Recent advances in investigational tools have improved our understanding of the physiology and pathophysiology of colonic and defecatory functions. In particular, colonic and anorectal high-resolution manometry are now available. High-resolution anorectal manometry, which is increasingly used in clinical practice, at least in the United States, provides a refined assessment of anorectal pressures and may uncover structural abnormalities. Advances in our understanding of colonic molecular physiology have led to the development of new therapeutic agents (such as secretagogues, pro-kinetics, inhibitors of bile acid transporters and ion exchangers). However, because clinical trials compare these newer agents with placebo, their efficacy relative to traditional laxatives is unknown. This article reviews these physiologic, diagnostic, and therapeutic advances and focuses particularly on newer therapeutic agents."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1640",
            "name": "Recent advances in understanding and managing chronic constipation"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding and managing chronic constipation </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17359 data-id=15900 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15900.1" data-recommended="" data-doi="10.12688/f1000research.15900.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1640/v1/pdf?article_uuid=2b847b95-548b-4c51-85bd-c9dd15c0f903" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-15900-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-15900-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-15900-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Prichard DO and Bharucha AE. Recent advances in understanding and managing chronic constipation [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1640 (<a class=new-orange href="https://doi.org/10.12688/f1000research.15900.1" target=_blank>https://doi.org/10.12688/f1000research.15900.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-15900-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=15900 id=track-article-signin-15900 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15900?target=/articles/7-1640">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17359 /> <input name=articleId type=hidden value=15900 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding and managing chronic constipation</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">David O. Prichard<a href="https://orcid.org/0000-0001-6861-2693" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-6861-2693</div><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:bharucha.adil@mayo.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Adil E. Bharucha</span></a><a href="https://orcid.org/0000-0002-7644-0390" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7644-0390</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">David O. Prichard<a href="http://orcid.org/0000-0001-6861-2693" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-6861-2693</div><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:bharucha.adil@mayo.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Adil E. Bharucha</span></a><a href="http://orcid.org/0000-0002-7644-0390" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7644-0390</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 15 Oct 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.15900.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA<br/> <sup>2</sup> Clinical Enteric Neuroscience Translational and Epidemiological Research Program and Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA<br/> <p> <div class=margin-bottom> David O. Prichard <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Adil E. Bharucha <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=35708-39298></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=40214-39299></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Constipation, a condition characterized by heterogeneous symptoms, is common in Western society. It is associated with reduced physical health, mental health, and social functioning. Because constipation is rarely due to a life-threatening disease (for example, colon cancer), current guidelines recommend empiric therapy. Limited surveys suggest that fewer than half of treated individuals are satisfied with treatment, perhaps because the efficacy of drugs is limited, they are associated with undesirable side effects, or they may not target the underlying pathophysiology. For example, although a substantial proportion of constipated patients have a defecatory disorder that is more appropriately treated with pelvic floor biofeedback therapy than with laxatives, virtually no pharmacological trials formally assessed for anorectal dysfunction. Recent advances in investigational tools have improved our understanding of the physiology and pathophysiology of colonic and defecatory functions. In particular, colonic and anorectal high-resolution manometry are now available. High-resolution anorectal manometry, which is increasingly used in clinical practice, at least in the United States, provides a refined assessment of anorectal pressures and may uncover structural abnormalities. Advances in our understanding of colonic molecular physiology have led to the development of new therapeutic agents (such as secretagogues, pro-kinetics, inhibitors of bile acid transporters and ion exchangers). However, because clinical trials compare these newer agents with placebo, their efficacy relative to traditional laxatives is unknown. This article reviews these physiologic, diagnostic, and therapeutic advances and focuses particularly on newer therapeutic agents. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Constipation, diagnosis, management, lubiprostone, linaclotide, plecanatide, prucalopride, velusetrag, elobixibat, NGM282, tenapanor </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Adil E. Bharucha (<a href="mailto:bharucha.adil@mayo.edu">bharucha.adil@mayo.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Adil E. Bharucha </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> AEB has received consulting fees from Asubio Pharmaceuticals, Ironwood Pharmaceuticals, Galcare Pharmaceuticals, and Medspira and has licensed patents to Medspira and Medtronic. DOP declares that he has no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported in part by US Public Health Service National Institutes of Health grant P01 DK68055. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Prichard DO and Bharucha AE. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Prichard DO and Bharucha AE. Recent advances in understanding and managing chronic constipation [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1640 (<a href="https://doi.org/10.12688/f1000research.15900.1" target=_blank>https://doi.org/10.12688/f1000research.15900.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 15 Oct 2018, <b>7</b>(F1000 Faculty Rev):1640 (<a href="https://doi.org/10.12688/f1000research.15900.1" target=_blank>https://doi.org/10.12688/f1000research.15900.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 15 Oct 2018, <b>7</b>(F1000 Faculty Rev):1640 (<a href="https://doi.org/10.12688/f1000research.15900.1" target=_blank>https://doi.org/10.12688/f1000research.15900.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d11268e161>Background</h2><p class="" id=d11268e164>Symptoms of constipation are reported by 10% to 20% of adults worldwide<sup><a href="#ref-1">1</a></sup>. Classically, the term “constipation” refers to infrequent bowel motions or hard feces. However, the disorder is heterogeneous; patients report a variety of symptoms including reduced bowel motion frequency, straining, hard stools, the sensation of incomplete emptying, the sensation of anal blockage, or the use of digitation or positioning to aid defecation (<a href="#T1">Box 1</a>)<sup><a href="#ref-2">2</a></sup>. In affected individuals, physical health, mental health, and social functioning are reduced<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. Despite this, only one-fifth of constipated individuals seek health-care advice<sup><a href="#ref-5">5</a></sup>. Yet, given the high prevalence of this condition, this represents over 8 million health-care visits<sup><a href="#ref-6">6</a></sup> and $230 million in costs<sup><a href="#ref-7">7</a></sup> annually in the United States.</p><p class="" id=d11268e198> <a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Box 1. Diagnostic criteria for functional constipation</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><a name=d11268e208 class=n-a></a><tbody><a name=d11268e210 class=n-a></a><tr><a name=d11268e212 class=n-a></a><td colspan=1 rowspan=1><a name=d11268e214 class=n-a></a> <b>Two or more of the following must be present</b> <br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Straining during more than one-fourth (25%) of defecations<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;II.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lumpy or hard stools (Bristol Stool Form Scale 1–2) in more than one-fourth (25%) of defecations<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;III.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sensation of incomplete evacuation in more than one-fourth (25%) of defecations<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IV.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sensation of anorectal obstruction/blockage in more than one-fourth (25%) of defecations<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;V.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Manual maneuvers to facilitate more than one-fourth (25%) of defecations (for example, digital evacuation and support of the pelvic floor)<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;VI.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fewer than three spontaneous bowel movements per week<br class=br><br class=br>These criteria must be fulfilled for the previous 3 months. The symptom onset must be at least 6 months prior to diagnosis.</td></tr><tr><a name=d11268e237 class=n-a></a><td colspan=1 rowspan=1><a name=d11268e239 class=n-a></a> <b>In addition</b> <br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loose stools are rarely present without the use of laxatives<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;II.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are insufficient criteria for irritable bowel syndrome</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d11268e254 class=n-a></a><p id=d11268e255> Based upon Mearin <i>et al</i>.<sup><a href="#ref-2">2</a></sup>.</p></div></div></div> </p><p class="" id=d11268e268>In the absence of alarm features, constipation is seldom due to a life-threatening organic disorder (for example, colon cancer) or another disease (for example, hypothyroidism). Hence, guidelines recommend initial empiric therapy for constipated patients rather than investigating for a cause (for example, with colonoscopy)<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. Likewise, although primary constipation generally results from slow colonic transit, impaired rectal evacuation, or both<sup><a href="#ref-8">8</a></sup>, tests to evaluate these processes are recommended only in patients who do not respond to laxatives.</p><p class="" id=d11268e282>Slow colonic transit is associated with hard stools<sup><a href="#ref-10">10</a></sup>. Consequently, osmotic and stimulant laxatives are the two most commonly prescribed agents<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>. Osmotic laxatives (for example, polyethylene glycol or lactulose) retain water in the intestinal lumen, accelerating colonic transit and reducing the consistency of evacuated stool. Stimulant laxatives (for example, senna, bisacodyl, or glycerin) stimulate colonic contractions and the urge to defecate. Although laxatives increase bowel motion frequency<sup><a href="#ref-13">13</a></sup>, satisfaction is variable<sup><a href="#ref-14">14</a></sup>. In an internet-based survey of 1,355 patients with self-reported constipation in 10 European countries in 2009, 855 patients were taking laxatives. Of these patients, 28% were very satisfied or satisfied with their treatment, 44% were neutral, and 28% were dissatisfied with therapy. In particular, the symptom of bloating persists<sup><a href="#ref-15">15</a></sup>. Conceptually, satisfaction may be suboptimal because the efficacy of drugs is limited, they are associated with undesirable side effects, or they may not target the underlying pathophysiology. In particular, a substantial proportion of constipated patients have a defecatory disorder that may be associated with normal or slow colonic transit. Defecatory disorders are more appropriately treated with pelvic floor biofeedback therapy than with laxatives<sup><a href="#ref-16">16</a>–<a href="#ref-18">18</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11268e319>Advances in understanding the molecular pathophysiology of constipation</h2><p class="" id=d11268e322>Abnormalities of ion channels within the intestine have been shown to affect secretion, absorption, motility, and sensation, potentially resulting in constipation, diarrhea, and irritable bowel syndrome (IBS)<sup><a href="#ref-19">19</a></sup>. The presence of these dysfunctional channels may be suggested by a family history of a functional bowel disorder<sup><a href="#ref-19">19</a></sup>. Documented “channelopathies” include those affecting the voltage-gated sodium channel Na<sub>V</sub>1.5, present on smooth muscle cells; the voltage-gated sodium channels Na<sub>V</sub>1.7 and Na<sub>V</sub>1.9, present on neurons; and ion exchange channels, present on enterocytes<sup><a href="#ref-19">19</a></sup>. Altered ion channel expression or function occurs because of genetic mutations, post-translational modification, or accessory protein malfunction. In particular, the voltage-gated sodium channel Na<sub>V</sub>1.5 has been associated with constipation<sup><a href="#ref-20">20</a></sup>. In one study, mutations, predominantly resulting in loss of function, were found in 7% of patients (4 out of 59) with constipation-predominant IBS (IBS-C)<sup><a href="#ref-20">20</a></sup>. Further studies are necessary to determine whether these mutations were responsible for the bowel symptoms.</p><p class="" id=d11268e358>In selected studies, about one in four patients with diarrhea-predominant IBS has high concentrations of fecal bile acids<sup><a href="#ref-21">21</a></sup>. Conversely, a small fraction (that is, about 6%) of patients with IBS-C have low fecal concentrations of bile acids<sup><a href="#ref-22">22</a></sup>. It is unclear to what extent these findings represent a primary disturbance (that is, due to reduced secretion or increased reabsorption or both) or are secondary to slow colon transit. Nonetheless, because bile acids stimulate colonic secretion of water and high-amplitude-propagated contractions<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>, it is hypothesized that a paucity of colonic bile acids may cause constipation. Indeed, the corollary is also true: excess bile acid administered orally<sup><a href="#ref-24">24</a></sup> or modification of the enterohepatic recycling pathway<sup><a href="#ref-25">25</a></sup> can exert a laxative effect.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11268e387>Normal and abnormal colonic and anal structure and function</h2><p class="" id=d11268e390>Defecation is an intricate viscerosomatic process<sup><a href="#ref-26">26</a></sup>, and the pathophysiology of defecatory disorders is heterogeneous. A clinical history is insufficient for differentiating the subtypes of constipation<sup><a href="#ref-27">27</a></sup>. A detailed digital rectal examination<sup><a href="#ref-28">28</a></sup> may suggest the presence of manometric features of a defecatory disorder—positive predictive value (PPV) of 97% and negative predictive value (NPV) of 37%—but is less useful for predicting an abnormal rectal balloon expulsion test (PPV of 33% and NPV of 65%)<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. Indeed, agreement among anorectal tests is variable, perhaps partly because they assess different aspects of structure or function or both<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>. Consequently, the Rome criteria recommend that when standard empiric laxative therapy fails to provide relief for patients with constipation, defecatory disturbances be documented with two tests<sup><a href="#ref-32">32</a></sup>. However, where manometry or defecography is not available, a digital rectal examination and balloon expulsion test are sufficient for screening.</p><p class="" id=d11268e424>A detailed rectoanal manometry and rectal balloon expulsion test can provide information regarding rectoanal neuromuscular functions<sup><a href="#ref-33">33</a></sup>. Relative to water-perfused manometry, high-resolution manometry is simpler to perform<sup><a href="#ref-34">34</a></sup>. However, in clinical practice, the incremental utility of high-resolution manometry above water-perfused manometry is unclear<sup><a href="#ref-33">33</a></sup>.</p><p class="" id=d11268e439>In contrast to high-resolution anorectal manometry, high-definition anorectal manometry provides a three-dimensional evaluation of pressures within the anal canal. To date, relatively small studies suggest that high-resolution and high-definition anorectal manometry have similar performance characteristics for evaluating anorectal disorders<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. In high-definition anorectal manometry, similar to high-resolution anorectal manometry, 70% of healthy individuals exhibit a dyssynergic manometry pattern during simulated evacuation<sup><a href="#ref-36">36</a></sup>. More recent studies observed that both high-resolution and high-definition anorectal manometry can identify rectoceles, intra-anal intussusception, and rectal prolapse<sup><a href="#ref-37">37</a>–<a href="#ref-40">40</a></sup>. However, whether these techniques will augment or supplant defecography, or fall by the wayside, for diagnosing these conditions has yet to be determined.</p><p class="" id=d11268e460>Within the colon, high-resolution manometry is better than standard water-perfused manometry for visualizing propagated colonic contractions<sup><a href="#ref-41">41</a></sup>. While high-resolution colonic manometry remains primarily a research tool, attempts are being made to incorporate these data into clinical practice. For example, among 18 pediatric patients with slow transit constipation and six children with normal transit constipation, manometric findings were predictive of neuropathy with a sensitivity of 100% and a specificity of 86%<sup><a href="#ref-42">42</a></sup>.</p><p class="" id=d11268e472>Radiological tests are also useful for evaluating anorectal and colonic functions. Barium defecography is used to exclude or diagnose rectoceles and pelvic organ prolapse causing obstructed defecation. Magnetic resonance imaging (MRI) defecography offers a radiation-free alternative. Furthermore, it provides a comprehensive evaluation of pelvic organ structure and function during defecation without the need to instill radiopaque material into the small bowel, bladder, or vagina. With the exception of internal intussusception<sup><a href="#ref-43">43</a></sup> and retentive rectoceles<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>, which are less frequently identified during MRI defecography, barium and MRI defecography have similar performance characteristics.</p><p class="" id=d11268e486>MRI has been used as a research tool to evaluate colonic motor function in constipation and IBS<sup><a href="#ref-46">46</a>–<a href="#ref-48">48</a></sup>. Inoh <i>et al</i>. evaluated the relationship between colonic diameter and gastrointestinal symptoms in 20 patients with self-reported chronic constipation by using abdominal MRI<sup><a href="#ref-49">49</a></sup>. Ascending colon diameter correlated with a sense of incomplete evacuation, and rectal diameter correlated with constipation scores<sup><a href="#ref-49">49</a></sup>. However, although the sum of all the segmental diameters (cecum, ascending, transverse, descending, sigmoid colon, and rectum) correlated with an increasing severity of constipation, the sum of certain segmental diameters also positively correlated with diarrhea. Furthermore, no statistical adjustment appears to have been made for the multiple comparisons performed in this study. Although the hypothesis is interesting, further studies are required to understand the relationship among colonic fecal volume, colonic diameter, and bowel function. Park <i>et al</i>. demonstrated that rectal gas volume was a marker of defecatory disorders; at a specificity of 90%, a rectal gas volume of 30 mL had a PPV of 77.3% for an evacuation disorder<sup><a href="#ref-50">50</a>,<a href="#ref-51">51</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11268e521>Development of novel therapeutic agents for the treatment of constipation</h2><p class="" id=d11268e524>A few medications that selectively target intestinal secretion or motility are available. Serotonin receptor agonists have been used to accelerate intestinal transit. Activation or inhibition of intestinal ionic transporters can increase luminal fluid content and accelerates the rate of colonic transit. Inhibition of ileal bile acid transporters exposes the colon to a greater concentration of these ionic detergents, resulting in the secretion of water into the colonic lumen and accelerated colonic transit.</p><div class=section><a name=d11268e527 class=n-a></a><h3 class=section-title>Selective 5-HT(4) receptor agonists: prucalopride and velusetrag</h3><p class="" id=d11268e532>Cisapride and tegaserod, the initial 5-HT(4) receptor agonists used to treat functional bowel disorders<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>, were withdrawn from the market because of cardiovascular events<sup><a href="#ref-54">54</a>–<a href="#ref-56">56</a></sup>. By targeting differing pharmacophores, with greater receptor selectivity, novel 5-HT(4) receptor agonists avoid this pro-arrhythmic risk<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>.</p><p class="" id=d11268e556>Prucalopride is a selective, high-affinity, 5-HT(4) receptor agonist with prokinetic gastrointestinal activity<sup><a href="#ref-59">59</a></sup>. Prucalopride accelerated colonic transit in healthy individuals<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup> and gastric, small bowel, and colonic transit in constipated patients<sup><a href="#ref-62">62</a></sup>. The initial phase 3, double-blind, parallel-group, placebo-controlled trials demonstrated that prucalopride was substantially more efficacious than placebo for increasing the number of spontaneous complete bowel movements by one per week (47% versus 26%, <i>p</i> &lt;0.001) and promoting more than three complete spontaneous bowel motions (CSBMs) per week (31% versus 12%, <i>p</i> &lt;0.001). Patients reported less-severe symptoms and improved satisfaction with their bowel function<sup><a href="#ref-63">63</a></sup>. Subsequent findings include improved constipation-related quality of life<sup><a href="#ref-64">64</a></sup>, satisfaction with prucalopride in patients who were dissatisfied with previous laxative treatments<sup><a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>, and efficacy for treating constipation in men<sup><a href="#ref-67">67</a></sup>, elderly patients<sup><a href="#ref-68">68</a></sup>, and patients with chronic intestinal pseudo-obstruction<sup><a href="#ref-69">69</a></sup>, opioid-induced constipation<sup><a href="#ref-70">70</a></sup>, or spinal cord injury<sup><a href="#ref-71">71</a></sup>. Moreover, prucalopride remains efficacious after 18 months of therapy<sup><a href="#ref-72">72</a></sup>. Only one study, a double-blind, placebo-controlled trial over 24 weeks, demonstrated no benefit above placebo<sup><a href="#ref-73">73</a></sup>. Even in older patients, the risk of cardiac events, including QT prolongation, is not increased<sup><a href="#ref-74">74</a>,<a href="#ref-75">75</a></sup>. Only 5% of patients discontinue the medication because of adverse effects (for example, abdominal pain, nausea, diarrhea, or headache)<sup><a href="#ref-72">72</a></sup>. Prucalopride is approved by the European Medicines Agency (EMA), but not by the US Food and Drug Administration (FDA), for the treatment of constipation.</p><p class="" id=d11268e636>Velusetrag (TD-5108), a newer selective 5-HT(4) receptor agonist, accelerates colonic and gastric transit<sup><a href="#ref-76">76</a>,<a href="#ref-77">77</a></sup>. A phase 2 trial of about 400 patients demonstrated a significant increase above placebo in the number of spontaneous bowel motions (about 3.5 versus 1.4, <i>p</i> &lt;0.001) and CSBMs per week (about 2 versus 0.6, <i>p</i> &lt;0.001) for all doses of velusetrag<sup><a href="#ref-78">78</a></sup>. A phase 2 trial of naronapride (ATI-7505) demonstrated beneficial physiological and clinical effects<sup><a href="#ref-79">79</a></sup>. These studies with velusetrag and ATI-7505 were published almost a decade ago. In November 2016, after a considerable delay, the FDA recommended that efficacy and cardiovascular safety of naronapride be evaluated in two additional phase 3 studies with 1,000 patients each<sup><a href="#ref-80">80</a></sup>. However, no phase 3 trials of velusetrag for constipation are currently registered on ClinicalTrials.gov. Another highly selective 5-HT(4) receptor agonist, YH12852, accelerated upper and lower intestinal transit in animal models<sup><a href="#ref-81">81</a></sup>. Human studies are awaited.</p></div><div class=section><a name=d11268e670 class=n-a></a><h3 class=section-title>Intestinal chloride channel activators: lubiprostone, linaclotide, and plecanatide</h3><p class="" id=d11268e675>The secretion of ions, and thereby fluid, into the intestinal lumen through ion channels can be pharmacologically driven by lubiprostone, linaclotide, and plecanatide. Activation of the cystic fibrosis transmembrane conductance regulator (CFTR) on the apical surface of enterocytes results in chloride secretion into the intestinal lumen, which is followed by a net secretion of sodium and subsequently water<sup><a href="#ref-82">82</a></sup>.</p><p class="" id=d11268e682>Lubiprostone is a prostaglandin E analog that activates apical type 2 chloride channels, prostaglandin EP receptors, and the apical CFTR<sup><a href="#ref-83">83</a></sup>. In a 4-week randomized parallel-group placebo-controlled phase 3 trial involving 237 patients with chronic constipation, lubiprostone (24 μg daily) was superior to placebo<sup><a href="#ref-84">84</a></sup>. Lubiprostone-treated patients experienced more frequent spontaneous bowel motions than those treated with placebo (5.9 versus 4.0, <i>p</i> &lt;0.001). Lubiprostone reduced bloating<sup><a href="#ref-85">85</a></sup> but did not affect pain thresholds during colonic distention<sup><a href="#ref-86">86</a></sup>. It is efficacious for treating constipation associated with cystic fibrosis<sup><a href="#ref-83">83</a></sup>, diabetes<sup><a href="#ref-87">87</a></sup>, and opioids<sup><a href="#ref-88">88</a></sup>. In general, lubiprostone is well tolerated. However, nausea (20%), diarrhea (10%), abdominal distension (7%), headache (7%), and abdominal pain (5%) are reported frequently<sup><a href="#ref-85">85</a></sup>.</p><p class="" id=d11268e721>Linaclotide and plecanatide are uroguanylin analogs that activate cell-surface guanylate cyclase-C receptors on enterocytes, inducing translocation of the CFTR to the apical surface of the cell. Initial studies of linaclotide demonstrated a dose-dependent increase in colonic transit with an associated increase in bowel motion frequency and consistency and reduced straining scores in patients with IBS-C<sup><a href="#ref-89">89</a></sup> and chronic constipation<sup><a href="#ref-90">90</a></sup>. Larger studies confirmed these findings, and only 4% of patients stopped the medication because of adverse side effects<sup><a href="#ref-91">91</a>–<a href="#ref-93">93</a></sup>. Linaclotide 145 μg and 290 μg increased the mean number of CSBMs per week to about 2.5 versus 0.9 with placebo (<i>p</i> &lt;0.001)<sup><a href="#ref-92">92</a></sup>. In rodent models of visceral pain, linaclotide reduced visceral sensitivity<sup><a href="#ref-94">94</a></sup>. Perhaps this explains, at least in part, why linaclotide reduced abdominal pain and improved bowel motion frequency and consistency in patients with IBS-C<sup><a href="#ref-95">95</a></sup>. These benefits appear to persist with longer-term administration<sup><a href="#ref-96">96</a></sup>.</p><p class="" id=d11268e759>In 2017, plecanatide, which works via mechanisms similar to those of linaclotide, was approved by the FDA for treating chronic idiopathic constipation<sup><a href="#ref-97">97</a></sup> based on a phase 3, multi-center, double-blind, placebo-controlled study of 1,394 patients<sup><a href="#ref-98">98</a></sup>. Plecanatide increased the weekly number of CSBMs (about 2.2 versus 1.2, <i>p</i> &lt;0.001) and spontaneous bowel motions (about 3.1 versus 1.3, <i>p</i> &lt;0.001) per week above those seen with placebo during a 12-week study. Adverse effects (most commonly diarrhea) occurred in about 6% of patients taking plecanatide and 1% of patients receiving placebo. Similar findings were reported elsewhere<sup><a href="#ref-99">99</a></sup>. An open-label follow-up study of 2,370 patients who had been enrolled in phase 2b or phase 3 studies demonstrated that 82% had completed or were still receiving the study drug<sup><a href="#ref-100">100</a></sup>. These patients reported a median satisfaction score for treatment of 4.0 (quite satisfied) and were “quite likely” to continue the medication. Animal models suggest that plecanatide, similar to linaclotide, also reduces visceral sensitivity<sup><a href="#ref-101">101</a></sup>, and phase 3 trials in patients with IBS-C have demonstrated a significant improvement in bowel motion frequency, stool consistency, and abdominal pain above that seen with placebo<sup><a href="#ref-102">102</a></sup>. Sustained response with the 6 mg dose of plecanatide was seen in 30% of patients in the first study (placebo response 18%, <i>p</i> &lt;0.001) and 24% in the second trial (14% placebo response, <i>p</i> &lt;0.001)<sup><a href="#ref-102">102</a></sup>. Additional CFTR activators (CFTRact-J027 and its derivatives) have demonstrated efficacy for treating constipation in mouse models<sup><a href="#ref-103">103</a>,<a href="#ref-104">104</a></sup>.</p></div><div class=section><a name=d11268e812 class=n-a></a><h3 class=section-title>Modifiers of bile acid recycling and synthesis: elobixibat and NGM282</h3><p class="" id=d11268e817>Elobixibat (A3309) is the first-in-class ileal bile acid transporter inhibitor<sup><a href="#ref-105">105</a></sup>. Inhibiting the absorption of bile acids from the ileum exposes the colonic mucosa to a higher concentration of these ionic detergents. This accelerates colonic transit, increases stool frequency, and potentially relieves the symptoms of constipation<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a>,<a href="#ref-106">106</a></sup>. In a randomized phase 2b trial, 190 patients with chronic constipation received 5, 10, or 15 mg of elobixibat or placebo once daily for 8 weeks. The times to the first spontaneous bowel motion and CSBM were significantly shortened in the 10 and 15 mg groups. Stool frequency and constipation-related symptoms were significantly improved<sup><a href="#ref-107">107</a></sup>. A phase 3 trial confirmed the efficacy of elobixibat for the treatment of chronic constipation but demonstrated that adverse drug reactions occur in up to half of patients<sup><a href="#ref-108">108</a></sup>. These are usually mild abdominal pain or diarrhea. Though approved for clinical use in Japan, elobixibat is not currently approved for use by the EMA or the FDA.</p><p class="" id=d11268e842>In patients with functional constipation, the fibroblast growth factor 19 analog NGM282 accelerated gastric and colonic transit, resulting in an increased number of bowel movements, looser stool form, and increased ease of stool passage<sup><a href="#ref-25">25</a></sup>. The rationale for this study was the observation that NGM282 induced diarrhea in phase 2 trials relating to type 2 diabetes, primary biliary cholangitis, and non-alcoholic steatohepatitis. However, NGM282 is a potent inhibitor of bile acid synthesis, and in this study, in contrast to the effect of elobixibat, bile acid concentration in stool was reduced. Further physiological studies are needed to elucidate how NGM282 exerts its effects.</p></div><div class=section><a name=d11268e851 class=n-a></a><h3 class=section-title>Sodium/hydrogen exchanger inhibitors: tenapanor</h3><p class="" id=d11268e856>Tenapanor (AZD1722) is a first-in-class, minimally absorbed, small-molecule inhibitor of the gastrointestinal sodium/hydrogen exchanger NHE3. It inhibits the absorption of dietary sodium and phosphate, which increases intestinal fluid volume and transit<sup><a href="#ref-109">109</a></sup>. The effect is more pronounced when tenapanor is administered pre-meal<sup><a href="#ref-110">110</a></sup>. A phase 2 randomized placebo-controlled trial of 356 patients—87% women, mean ± standard deviation (SD) of 46 ± 13 years—with IBS-C demonstrated a CSBM responder rate of 61% with tenapanor 50 mg twice a day as compared with 34% in the placebo group (<i>p</i> &lt;0.001). Additionally, abdominal pain was significantly reduced in the tenapanor group<sup><a href="#ref-111">111</a></sup>. The most common adverse events were diarrhea, headache, nausea, urinary tract infection, and abdominal pain. Diarrhea occurred in 9% of patients and resulted in medication cessation in 3%. Of note, data regarding the effect of tenapanor on hyperphosphatemia in patients with chronic kidney disease, which encompassed an older patient cohort (mean ± SD of 59 ± 14 years), demonstrated a similar side effect profile<sup><a href="#ref-112">112</a></sup>. Thereafter, two phase 3 trials in IBS-C, each with about 600 patients treated for 12 and 26 weeks, have been reported. In the first phase 3 trial, tenapanor met its primary endpoint (combined pain and stool pattern responder rate of 27% versus 19% with placebo, <i>p</i> = 0.02)<sup><a href="#ref-113">113</a></sup>. Significance was met for the secondary endpoint of abdominal pain relief but not for the CSBM endpoint. In the second study, tenapanor met all primary and secondary endpoints<sup><a href="#ref-114">114</a></sup>; the company plans to submit an application to the FDA in the second half of 2018. Tenapanor is not licensed by the EMA.</p></div><div class=section><a name=d11268e891 class=n-a></a><h3 class=section-title>New but not necessarily better</h3><p class="" id=d11268e896>Although these new agents are efficacious, only two studies have directly compared the clinical efficacy of newer and older laxatives. The first study compared polyethylene glycol with tegaserod, which has since been withdrawn from the market, in a randomized open-label, parallel-group study of 237 patients. Polyethylene glycol was better for improving symptoms of constipation. In the second, a randomized, double-blind, double-dummy study of 240 patients with chronic constipation, polyethylene glycol with electrolytes was compared with prucalopride<sup><a href="#ref-115">115</a></sup>. Polyethylene glycol with electrolytes was non-inferior to prucalopride for promoting more than three CSBMs per week and was better tolerated.</p><p class="" id=d11268e903>Indeed, a network meta-analysis comparing prucalopride, lubiprostone, linaclotide, tegaserod, velusetrag, elobixibat, bisacodyl, and sodium picosulfate was undertaken, albeit with limited data for some medications, and observed that these drugs were of comparable efficacy for the endpoints of at least three CSBMs per week or an increase over baseline of at least one CSBM per week. Bisacodyl was superior to the other agents for inducing a greater change from baseline in the number of spontaneous bowel motions per week<sup><a href="#ref-116">116</a></sup>.</p><p class="" id=d11268e910>Furthermore, the newer laxatives are much more expensive than the older, over-the-counter agents. In the United States, a 30-day supply of lubiprostone, linaclotide, or plecanatide costs about $450. By comparison, a 30-day supply of psyllium, polyethylene glycol, bisacodyl, or senna costs less than $10, whereas lactulose costs less than $15.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11268e917>Optimizing therapy and the potential role for individualized treatment of constipation</h2><p class="" id=d11268e920>Consensus guidelines recommend that pelvic floor biofeedback therapy, not laxatives, is the cornerstone for managing defecatory disorders<sup><a href="#ref-8">8</a></sup>. However, none of the pharmacological studies described above rigorously evaluated anorectal function and excluded patients with defecatory disorders. Therefore, the relative efficacy of these drugs in patients with isolated normal or slow transit constipation is unknown.</p><p class="" id=d11268e927>Where constipation does not respond to empiric therapy and a defecatory disorder has been excluded, investigation could guide tailored therapy. For example, the 5-HT(4) receptor agonist prucalopride might be a preferential choice for patients with diffusely slow intestinal transit. Ileal bile acid transporter inhibitors could be of benefit for constipated patients with a deficiency of bile acids reaching the colon. A single case report observed that mexiletine normalized bowel functions in a patient with IBS-C and a mutation in the <i>SCN5A</i> gene, which encodes the alpha-subunit of the voltage-gated sodium channel Na<sub>V</sub>1.5<sup><a href="#ref-20">20</a></sup>.</p><p class="" id=d11268e940>Future studies should evaluate the efficacy of novel and standard laxatives in patients with defined normal or slow transit constipation and the efficacy of targeted therapy (for example, with ileal bile acid transporter inhibitors in constipated patients with a deficiency of bile acids reaching the colon).</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11268e947>Summary and conclusions</h2><p class="" id=d11268e950>Constipation is common, but the underlying pathophysiology remains unclear in many cases. Many patients can be effectively and inexpensively treated with simple laxatives. Newer intestinal secretagogues and promotility agents are more expensive and should be considered in patients who do not respond to simple laxatives. A few new agents are being evaluated in clinical trials. There is a critical need to compare the efficacy of these newer agents relative to established laxatives and also clarify their efficacy in the subtypes of constipation (that is, normal transit, slow transit, and defecatory disorders).</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d11268e1 class=n-a></a><h2 class=main-title id=d11616>Grant information</h2><p>This work was supported in part by US Public Health Service National Institutes of Health grant P01 DK68055.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d11268e957 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d12010>References</h2><div class="section ref-list"><a name=d11268e957 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d11268e964 class=n-a></a>Mugie SM, Benninga MA, Di Lorenzo C: Epidemiology of constipation in children and adults: a systematic review. <i>Best Pract Res Clin Gastroenterol.</i> 2011; <b>25</b>(1): 3–18. <a target=xrefwindow id=d11268e972 href="http://www.ncbi.nlm.nih.gov/pubmed/21382575">PubMed Abstract </a> | <a target=xrefwindow id=d11268e975 href="http://dx.doi.org/10.1016/j.bpg.2010.12.010">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d11268e984 class=n-a></a>Mearin F, Lacy BE, Chang L, <i> et al.</i>: Bowel Disorders. <i>Gastroenterology.</i> 2016; pii: S0016-5085(16)00222-5. <a target=xrefwindow id=d11268e992 href="http://www.ncbi.nlm.nih.gov/pubmed/27144627">PubMed Abstract </a> | <a target=xrefwindow id=d11268e995 href="http://dx.doi.org/10.1053/j.gastro.2016.02.031">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d11268e1004 class=n-a></a>Belsey J, Greenfield S, Candy D, <i> et al.</i>: Systematic review: impact of constipation on quality of life in adults and children. <i>Aliment Pharmacol Ther.</i> 2010; <b>31</b>(9): 938–49. <a target=xrefwindow id=d11268e1015 href="http://www.ncbi.nlm.nih.gov/pubmed/20180788">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1018 href="http://dx.doi.org/10.1111/j.1365-2036.2010.04273.x">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d11268e1027 class=n-a></a>Heidelbaugh JJ, Stelwagon M, Miller SA, <i> et al.</i>: The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden. <i>Am J Gastroenterol.</i> 2015; <b>110</b>(4): 580–7. <a target=xrefwindow id=d11268e1038 href="http://www.ncbi.nlm.nih.gov/pubmed/25781368">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1041 href="http://dx.doi.org/10.1038/ajg.2015.67">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1045 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4424385">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d11268e1054 class=n-a></a>Drossman DA, Li Z, Andruzzi E, Temple RD, <i> et al.</i>: U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. <i>Dig Dis Sci.</i> 1993; <b>38</b>(9): 1569–80. <a target=xrefwindow id=d11268e1065 href="http://www.ncbi.nlm.nih.gov/pubmed/8359066">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1068 href="http://dx.doi.org/10.1007/BF01303162">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d11268e1078 class=n-a></a>Shah ND, Chitkara DK, Locke GR, <i> et al.</i>: Ambulatory care for constipation in the United States, 1993-2004. <i>Am J Gastroenterol.</i> 2008; <b>103</b>(7): 1746–53. <a target=xrefwindow id=d11268e1089 href="http://www.ncbi.nlm.nih.gov/pubmed/18557708">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1092 href="http://dx.doi.org/10.1111/j.1572-0241.2008.01910.x">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d11268e1101 class=n-a></a>Martin BC, Barghout V, Cerulli A: Direct medical costs of constipation in the United States. <i>Manag Care Interface.</i> 2006; <b>19</b>(12): 43–9. <a target=xrefwindow id=d11268e1109 href="http://www.ncbi.nlm.nih.gov/pubmed/17274481">PubMed Abstract </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d11268e1118 class=n-a></a>Bharucha AE, Pemberton JH, Locke GR 3rd: American Gastroenterological Association technical review on constipation. <i>Gastroenterology.</i> 2013; <b>144</b>(1): 218–38. <a target=xrefwindow id=d11268e1126 href="http://www.ncbi.nlm.nih.gov/pubmed/23261065">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1129 href="http://dx.doi.org/10.1053/j.gastro.2012.10.028">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1132 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3531555">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d11268e1141 class=n-a></a>Wald A, Bharucha AE, Cosman BC, <i> et al.</i>: ACG clinical guideline: management of benign anorectal disorders. <i>Am J Gastroenterol.</i> 2014; <b>109</b>(8): 1141–57; (Quiz) 1058. <a target=xrefwindow id=d11268e1152 href="http://www.ncbi.nlm.nih.gov/pubmed/25022811">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1155 href="http://dx.doi.org/10.1038/ajg.2014.190">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d11268e1164 class=n-a></a>Degen LP, Phillips SF: How well does stool form reflect colonic transit? <i>Gut.</i> 1996; <b>39</b>(1): 109–13. <a target=xrefwindow id=d11268e1172 href="http://www.ncbi.nlm.nih.gov/pubmed/8881820">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1175 href="http://dx.doi.org/10.1136/gut.39.1.109">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1178 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1383242">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d11268e1187 class=n-a></a>Shafe AC, Lee S, Dalrymple JS, <i> et al.</i>: The LUCK study: Laxative Usage in patients with GP-diagnosed Constipation in the UK, within the general population and in pregnancy. An epidemiological study using the General Practice Research Database (GPRD). <i>Therap Adv Gastroenterol.</i> 2011; <b>4</b>(6): 343–63. <a target=xrefwindow id=d11268e1198 href="http://www.ncbi.nlm.nih.gov/pubmed/22043228">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1201 href="http://dx.doi.org/10.1177/1756283X11417483">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1205 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3187684">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d11268e1215 class=n-a></a>Menees SB, Guentner A, Chey SW, <i> et al.</i>: How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation? <i>Am J Gastroenterol.</i> 2015; <b>110</b>(11): 1516–25. <a target=xrefwindow id=d11268e1226 href="http://www.ncbi.nlm.nih.gov/pubmed/26054623">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1229 href="http://dx.doi.org/10.1038/ajg.2015.156">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d11268e1238 class=n-a></a>Paré P, Fedorak RN: Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation. <i>Can J Gastroenterol Hepatol.</i> 2014; <b>28</b>(10): 549–57. <a target=xrefwindow id=d11268e1246 href="http://www.ncbi.nlm.nih.gov/pubmed/25390617">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1249 href="http://dx.doi.org/10.1155/2014/631740">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1252 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4234355">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d11268e1261 class=n-a></a>Müller-Lissner S, Tack J, Feng Y, <i> et al.</i>: Levels of satisfaction with current chronic constipation treatment options in Europe - an internet survey. <i>Aliment Pharmacol Ther.</i> 2013; <b>37</b>(1): 137–45. <a target=xrefwindow id=d11268e1272 href="http://www.ncbi.nlm.nih.gov/pubmed/23126338">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1275 href="http://dx.doi.org/10.1111/apt.12124">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d11268e1284 class=n-a></a>Emmanuel A, Quigley EM, Simrén M, <i> et al.</i>: Factors affecting satisfaction with treatment in European women with chronic constipation: An internet survey. <i>United European Gastroenterol J.</i> 2013; <b>1</b>(5): 375–84. <a target=xrefwindow id=d11268e1295 href="http://www.ncbi.nlm.nih.gov/pubmed/24917986">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1298 href="http://dx.doi.org/10.1177/2050640613494200">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1302 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4040768">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d11268e1311 class=n-a></a>Noelting J, Eaton JE, Choung RS, <i> et al.</i>: The incidence rate and characteristics of clinically diagnosed defecatory disorders in the community. <i>Neurogastroenterol Motil.</i> 2016; <b>28</b>(11): 1690–7. <a target=xrefwindow id=d11268e1322 href="http://www.ncbi.nlm.nih.gov/pubmed/27254309">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1325 href="http://dx.doi.org/10.1111/nmo.12868">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1329 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5083162">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d11268e1338 class=n-a></a>Rao SS, Mudipalli RS, Stessman M, <i> et al.</i>: Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). <i>Neurogastroenterol Motil.</i> 2004; <b>16</b>(5): 589–96. <a target=xrefwindow id=d11268e1349 href="http://www.ncbi.nlm.nih.gov/pubmed/15500515">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1352 href="http://dx.doi.org/10.1111/j.1365-2982.2004.00526.x">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d11268e1362 class=n-a></a>Chiarioni G, Salandini L, Whitehead WE: Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. <i>Gastroenterology.</i> 2005; <b>129</b>(1): 86–97. <a target=xrefwindow id=d11268e1370 href="http://www.ncbi.nlm.nih.gov/pubmed/16012938">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1373 href="http://dx.doi.org/10.1053/j.gastro.2005.05.015">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726639527"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e1382 class=n-a></a>Beyder A, Farrugia G: Ion channelopathies in functional GI disorders. <i>Am J Physiol Gastrointest Liver Physiol.</i> 2016; <b>311</b>(4): G581–G586. <a target=xrefwindow id=d11268e1390 href="http://www.ncbi.nlm.nih.gov/pubmed/27514480">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1393 href="http://dx.doi.org/10.1152/ajpgi.00237.2016">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1396 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5142191">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726639527">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718304798"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e1409 class=n-a></a>Beyder A, Mazzone A, Strege PR, <i> et al.</i>: Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. <i>Gastroenterology.</i> 2014; <b>146</b>(7): 1659–68. <a target=xrefwindow id=d11268e1420 href="http://www.ncbi.nlm.nih.gov/pubmed/24613995">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1423 href="http://dx.doi.org/10.1053/j.gastro.2014.02.054">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1427 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4096335">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718304798">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d11268e1440 class=n-a></a>Slattery SA, Niaz O, Aziz Q, <i> et al.</i>: Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. <i>Aliment Pharmacol Ther.</i> 2015; <b>42</b>(1): 3–11. <a target=xrefwindow id=d11268e1451 href="http://www.ncbi.nlm.nih.gov/pubmed/25913530">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1454 href="http://dx.doi.org/10.1111/apt.13227">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727764816"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e1463 class=n-a></a>Vijayvargiya P, Busciglio I, Burton D, <i> et al.</i>: Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples. <i>Clin Gastroenterol Hepatol.</i> 2018; <b>16</b>(4): 522–7. <a target=xrefwindow id=d11268e1474 href="http://www.ncbi.nlm.nih.gov/pubmed/28666948">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1477 href="http://dx.doi.org/10.1016/j.cgh.2017.06.039">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1481 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5745308">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727764816">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d11268e1494 class=n-a></a>Thaysen EH, Pedersen L: Idiopathic bile acid catharsis. <i>Gut.</i> 1976; <b>17</b>(12): 965–70. <a target=xrefwindow id=d11268e1502 href="http://www.ncbi.nlm.nih.gov/pubmed/1017717">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1505 href="http://dx.doi.org/10.1136/gut.17.12.965">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1508 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1411224">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/6450956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e1518 class=n-a></a>Rao AS, Wong BS, Camilleri M, <i> et al.</i>: Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. <i>Gastroenterology.</i> 2010; <b>139</b>(5): 1549–58, 1558.e1. <a target=xrefwindow id=d11268e1529 href="http://www.ncbi.nlm.nih.gov/pubmed/20691689">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1532 href="http://dx.doi.org/10.1053/j.gastro.2010.07.052">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1536 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3189402">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/6450956">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733160384"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e1549 class=n-a></a>Oduyebo I, Camilleri M, Nelson AD, <i> et al.</i>: Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial. <i>Am J Gastroenterol.</i> 2018; <b>113</b>(5): 725–34. <a target=xrefwindow id=d11268e1560 href="http://www.ncbi.nlm.nih.gov/pubmed/29717197">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1563 href="http://dx.doi.org/10.1038/s41395-018-0042-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733160384">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d11268e1576 class=n-a></a>Bharucha AE: Pelvic floor: anatomy and function. <i>Neurogastroenterol Motil.</i> 2006; <b>18</b>(7): 507–19. <a target=xrefwindow id=d11268e1584 href="http://www.ncbi.nlm.nih.gov/pubmed/16771766">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1587 href="http://dx.doi.org/10.1111/j.1365-2982.2006.00803.x">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717978501"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e1596 class=n-a></a>Ratuapli SK, Bharucha AE, Noelting J, <i> et al.</i>: Phenotypic identification and classification of functional defecatory disorders using high-resolution anorectal manometry. <i>Gastroenterology.</i> 2013; <b>144</b>(2): 314–322.e2. <a target=xrefwindow id=d11268e1607 href="http://www.ncbi.nlm.nih.gov/pubmed/23142135">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1610 href="http://dx.doi.org/10.1053/j.gastro.2012.10.049">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1614 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3681888">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717978501">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d11268e1627 class=n-a></a>Rao SSC: Rectal Exam: Yes, it can and should be done in a busy practice! <i>Am J Gastroenterol.</i> 2018; <b>113</b>(5): 635–8. <a target=xrefwindow id=d11268e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/29453382">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1638 href="http://dx.doi.org/10.1038/s41395-018-0006-y">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d11268e1647 class=n-a></a>Tantiphlachiva K, Rao P, Attaluri A, <i> et al.</i>: Digital rectal examination is a useful tool for identifying patients with dyssynergia. <i>Clin Gastroenterol Hepatol.</i> 2010; <b>8</b>(11): 955–60. <a target=xrefwindow id=d11268e1658 href="http://www.ncbi.nlm.nih.gov/pubmed/20656061">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1661 href="http://dx.doi.org/10.1016/j.cgh.2010.06.031">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d11268e1671 class=n-a></a>Soh JS, Lee HJ, Jung KW, <i> et al.</i>: The diagnostic value of a digital rectal examination compared with high-resolution anorectal manometry in patients with chronic constipation and fecal incontinence. <i>Am J Gastroenterol.</i> 2015; <b>110</b>(8): 1197–204. <a target=xrefwindow id=d11268e1682 href="http://www.ncbi.nlm.nih.gov/pubmed/26032152">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1685 href="http://dx.doi.org/10.1038/ajg.2015.153">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d11268e1694 class=n-a></a>Carrington EV, Scott SM, Bharucha A, <i> et al.</i>: Expert consensus document: Advances in the evaluation of anorectal function. <i>Nat Rev Gastroenterol Hepatol.</i> 2018; <b>15</b>(5): 309–23. <a target=xrefwindow id=d11268e1705 href="http://www.ncbi.nlm.nih.gov/pubmed/29636555">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1708 href="http://dx.doi.org/10.1038/nrgastro.2018.27">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1712 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6028941">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d11268e1721 class=n-a></a>Rao SS, Bharucha AE, Chiarioni G, <i> et al.</i>: Functional Anorectal Disorders. <i>Gastroenterology.</i> 2016; <b>150</b>(6): 1430–1442.e4, pii: S0016-5085(16)00175-X. <a target=xrefwindow id=d11268e1732 href="http://www.ncbi.nlm.nih.gov/pubmed/27144630">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1735 href="http://dx.doi.org/10.1053/j.gastro.2016.02.009">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1739 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5035713">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d11268e1748 class=n-a></a>Basilisco G, Bharucha AE: High-resolution anorectal manometry: An expensive hobby or worth every penny? <i>Neurogastroenterol Motil.</i> 2017; <b>29</b>(8): e13125. <a target=xrefwindow id=d11268e1756 href="http://www.ncbi.nlm.nih.gov/pubmed/28699318">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1759 href="http://dx.doi.org/10.1111/nmo.13125">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1762 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5609826">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d11268e1771 class=n-a></a>Kang HR, Lee JE, Lee JS, <i> et al.</i>: Comparison of High-resolution Anorectal Manometry With Water-perfused Anorectal Manometry. <i>J Neurogastroenterol Motil.</i> 2015; <b>21</b>(1): 126–32. <a target=xrefwindow id=d11268e1782 href="http://www.ncbi.nlm.nih.gov/pubmed/25537672">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1785 href="http://dx.doi.org/10.5056/jnm14025">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1789 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4288094">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d11268e1798 class=n-a></a>Chakraborty S, Feuerhak KJ, Zinsmeister AR, <i> et al.</i>: Reproducibility of high-definition (3D) manometry and its agreement with high-resolution (2D) manometry in women with fecal incontinence. <i>Neurogastroenterol Motil.</i> 2017; <b>29</b>(3): e12950. <a target=xrefwindow id=d11268e1809 href="http://www.ncbi.nlm.nih.gov/pubmed/27696628">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1812 href="http://dx.doi.org/10.1111/nmo.12950">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1816 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5329128">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727365379"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e1826 class=n-a></a>Mion F, Garros A, Brochard C, <i> et al.</i>: 3D High-definition anorectal manometry: Values obtained in asymptomatic volunteers, fecal incontinence and chronic constipation. Results of a prospective multicenter study (NOMAD). <i>Neurogastroenterol Motil.</i> 2017; <b>29</b>(8): e13049. <a target=xrefwindow id=d11268e1837 href="http://www.ncbi.nlm.nih.gov/pubmed/28251732">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1840 href="http://dx.doi.org/10.1111/nmo.13049">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727365379">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725335371"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e1853 class=n-a></a>Heinrich H, Sauter M, Fox M, <i> et al.</i>: Assessment of Obstructive Defecation by High-Resolution Anorectal Manometry Compared With Magnetic Resonance Defecography. <i>Clin Gastroenterol Hepatol.</i> 2015; <b>13</b>(7): 1310–1317.e1. <a target=xrefwindow id=d11268e1864 href="http://www.ncbi.nlm.nih.gov/pubmed/25638584">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1867 href="http://dx.doi.org/10.1016/j.cgh.2015.01.017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725335371">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d11268e1880 class=n-a></a>Prichard DO, Lee T, Parthasarathy G, <i> et al.</i>: High-resolution Anorectal Manometry for Identifying Defecatory Disorders and Rectal Structural Abnormalities in Women. <i>Clin Gastroenterol Hepatol.</i> 2017; <b>15</b>(3): 412–20. <a target=xrefwindow id=d11268e1891 href="http://www.ncbi.nlm.nih.gov/pubmed/27720913">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1894 href="http://dx.doi.org/10.1016/j.cgh.2016.09.154">Publisher Full Text </a> | <a target=xrefwindow id=d11268e1898 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5316318">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d11268e1907 class=n-a></a>Brusciano L, Tolone S, Limongelli P, <i> et al.</i>: Anatomical and Functional Features of the Internal Rectal Prolapse With Outlet Obstruction Determined With 3D Endorectal Ultrasonography and High-Resolution Anorectal Manometry: An Observational Case-Control Study. <i>Am J Gastroenterol.</i> 2018; <b>113</b>(8): 1247–50. <a target=xrefwindow id=d11268e1918 href="http://www.ncbi.nlm.nih.gov/pubmed/29915399">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1921 href="http://dx.doi.org/10.1038/s41395-018-0141-5">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727038173"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e1930 class=n-a></a>Benezech A, Cappiello M, Baumstarck K, <i> et al.</i>: Rectal intussusception: can high resolution three-dimensional ano-rectal manometry compete with conventional defecography? <i>Neurogastroenterol Motil.</i> 2017; <b>29</b>(4): e12978. <a target=xrefwindow id=d11268e1941 href="http://www.ncbi.nlm.nih.gov/pubmed/27891706">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1944 href="http://dx.doi.org/10.1111/nmo.12978">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727038173">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d11268e1957 class=n-a></a>Corsetti M, Pagliaro G, Demedts I, <i> et al.</i>: Pan-Colonic Pressurizations Associated With Relaxation of the Anal Sphincter in Health and Disease: A New Colonic Motor Pattern Identified Using High-Resolution Manometry. <i>Am J Gastroenterol.</i> 2017; <b>112</b>(3): 479–89. <a target=xrefwindow id=d11268e1968 href="http://www.ncbi.nlm.nih.gov/pubmed/27596695">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1971 href="http://dx.doi.org/10.1038/ajg.2016.341">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d11268e1981 class=n-a></a>Giorgio V, Borrelli O, Smith VV, <i> et al.</i>: High-resolution colonic manometry accurately predicts colonic neuromuscular pathological phenotype in pediatric slow transit constipation. <i>Neurogastroenterol Motil.</i> 2013; <b>25</b>(1): 70–8.e8-9. <a target=xrefwindow id=d11268e1992 href="http://www.ncbi.nlm.nih.gov/pubmed/23030503">PubMed Abstract </a> | <a target=xrefwindow id=d11268e1995 href="http://dx.doi.org/10.1111/nmo.12016">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d11268e2004 class=n-a></a>Pilkington SA, Nugent KP, Brenner J, <i> et al.</i>: Barium proctography <i>vs</i> magnetic resonance proctography for pelvic floor disorders: a comparative study. <i>Colorectal Dis.</i> 2012; <b>14</b>(10): 1224–30. <a target=xrefwindow id=d11268e2018 href="http://www.ncbi.nlm.nih.gov/pubmed/22251617">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2022 href="http://dx.doi.org/10.1111/j.1463-1318.2012.02945.x">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d11268e2031 class=n-a></a>van Iersel JJ, Formijne Jonkers HA, Verheijen PM, <i> et al.</i>: Comparison of dynamic magnetic resonance defaecography with rectal contrast and conventional defaecography for posterior pelvic floor compartment prolapse. <i>Colorectal Dis.</i> 2017; <b>19</b>(1): O46–O53. <a target=xrefwindow id=d11268e2042 href="http://www.ncbi.nlm.nih.gov/pubmed/27870169">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2045 href="http://dx.doi.org/10.1111/codi.13563">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d11268e2054 class=n-a></a>Zafar A, Seretis C, Feretis M, <i> et al.</i>: Comparative study of magnetic resonance defaecography and evacuation proctography in the evaluation of obstructed defaecation. <i>Colorectal Dis.</i> 2017; <b>19</b>(6): O204–O209. <a target=xrefwindow id=d11268e2065 href="http://www.ncbi.nlm.nih.gov/pubmed/28304122">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2068 href="http://dx.doi.org/10.1111/codi.13657">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d11268e2077 class=n-a></a>Nilsson M, Sandberg TH, Poulsen JL, <i> et al.</i>: Quantification and variability in colonic volume with a novel magnetic resonance imaging method. <i>Neurogastroenterol Motil.</i> 2015; <b>27</b>(12): 1755–63. <a target=xrefwindow id=d11268e2088 href="http://www.ncbi.nlm.nih.gov/pubmed/26598050">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2091 href="http://dx.doi.org/10.1111/nmo.12673">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d11268e2100 class=n-a></a>Sandberg TH, Nilsson M, Poulsen JL, <i> et al.</i>: A novel semi-automatic segmentation method for volumetric assessment of the colon based on magnetic resonance imaging. <i>Abdom Imaging.</i> 2015; <b>40</b>(7): 2232–41. <a target=xrefwindow id=d11268e2111 href="http://www.ncbi.nlm.nih.gov/pubmed/26054979">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2114 href="http://dx.doi.org/10.1007/s00261-015-0475-z">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d11268e2124 class=n-a></a>Lam C, Chaddock G, Marciani L, <i> et al.</i>: Colonic response to laxative ingestion as assessed by MRI differs in constipated irritable bowel syndrome compared to functional constipation. <i>Neurogastroenterol Motil.</i> 2016; <b>28</b>(6): 861–70. <a target=xrefwindow id=d11268e2135 href="http://www.ncbi.nlm.nih.gov/pubmed/26871949">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2138 href="http://dx.doi.org/10.1111/nmo.12784">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2142 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4949702">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d11268e2151 class=n-a></a>Inoh Y, Kanoshima K, Ohkuma K, <i> et al.</i>: Assessment of colonic contents in patients with chronic constipation using MRI. <i>J Clin Biochem Nutr.</i> 2018; <b>62</b>(3): 277–80. <a target=xrefwindow id=d11268e2162 href="http://www.ncbi.nlm.nih.gov/pubmed/29892169">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2165 href="http://dx.doi.org/10.3164/jcbn.17-104">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2169 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5990404">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727374903"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e2178 class=n-a></a>Park SY, Khemani D, Acosta A, <i> et al.</i>: Rectal gas volume: Defining cut-offs for screening for evacuation disorders in patients with constipation. <i>Neurogastroenterol Motil.</i> 2017; <b>29</b>(7): e13044. <a target=xrefwindow id=d11268e2189 href="http://www.ncbi.nlm.nih.gov/pubmed/28261935">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2192 href="http://dx.doi.org/10.1111/nmo.13044">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2196 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5466461">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727374903">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d11268e2209 class=n-a></a>Park SY, Khemani D, Nelson AD, <i> et al.</i>: Rectal Gas Volume Measured by Computerized Tomography Identifies Evacuation Disorders in Patients With Constipation. <i>Clin Gastroenterol Hepatol.</i> 2017; <b>15</b>(4): 543–552.e4. <a target=xrefwindow id=d11268e2220 href="http://www.ncbi.nlm.nih.gov/pubmed/27856363">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2223 href="http://dx.doi.org/10.1016/j.cgh.2016.11.013">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2227 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5362281">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d11268e2236 class=n-a></a>Quigley EM: Cisapride: what can we learn from the rise and fall of a prokinetic? <i>J Dig Dis.</i> 2011; <b>12</b>(3): 147–56. <a target=xrefwindow id=d11268e2244 href="http://www.ncbi.nlm.nih.gov/pubmed/21615867">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2247 href="http://dx.doi.org/10.1111/j.1751-2980.2011.00491.x">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d11268e2256 class=n-a></a>Chey WD: Review article: tegaserod -- the global experience. <i>Aliment Pharmacol Ther.</i> 2004; <b>20 Suppl 7</b>: 15–9. <a target=xrefwindow id=d11268e2264 href="http://www.ncbi.nlm.nih.gov/pubmed/15521850">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2267 href="http://dx.doi.org/10.1111/j.1365-2036.2004.02181.x">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d11268e2277 class=n-a></a>Hennessy S, Leonard CE, Newcomb C, <i> et al.</i>: Cisapride and ventricular arrhythmia. <i>Br J Clin Pharmacol.</i> 2008; <b>66</b>(3): 375–85. <a target=xrefwindow id=d11268e2288 href="http://www.ncbi.nlm.nih.gov/pubmed/18662288">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2291 href="http://dx.doi.org/10.1111/j.1365-2125.2008.03249.x">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2295 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2526241">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d11268e2304 class=n-a></a>Wysowski DK, Corken A, Gallo-Torres H, <i> et al.</i>: Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions. <i>Am J Gastroenterol.</i> 2001; <b>96</b>(6): 1698–703. <a target=xrefwindow id=d11268e2315 href="http://www.ncbi.nlm.nih.gov/pubmed/11419817">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2318 href="http://dx.doi.org/10.1111/j.1572-0241.2001.03927.x">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d11268e2327 class=n-a></a>Thompson CA: Novartis suspends tegaserod sales at FDA's request. <i>Am J Health Syst Pharm.</i> 2007; <b>64</b>(10): 1020. <a target=xrefwindow id=d11268e2335 href="http://www.ncbi.nlm.nih.gov/pubmed/17494895">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2338 href="http://dx.doi.org/10.2146/news070044">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d11268e2347 class=n-a></a>Potet F, Bouyssou T, Escande D, <i> et al.</i>: Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K<sup>+</sup> channel. <i>J Pharmacol Exp Ther.</i> 2001; <b>299</b>(3): 1007–12. <a target=xrefwindow id=d11268e2361 href="http://www.ncbi.nlm.nih.gov/pubmed/11714889">PubMed Abstract </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d11268e2370 class=n-a></a>Rampe D, Roy ML, Dennis A, <i> et al.</i>: A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. <i>FEBS Lett.</i> 1997; <b>417</b>(1): 28–32. <a target=xrefwindow id=d11268e2381 href="http://www.ncbi.nlm.nih.gov/pubmed/9395068">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2384 href="http://dx.doi.org/10.1016/S0014-5793(97)01249-0">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d11268e2393 class=n-a></a>Bharucha AE, Wouters MM, Tack J: Existing and emerging therapies for managing constipation and diarrhea. <i>Curr Opin Pharmacol.</i> 2017; <b>37</b>: 158–66. <a target=xrefwindow id=d11268e2401 href="http://www.ncbi.nlm.nih.gov/pubmed/29172123">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2404 href="http://dx.doi.org/10.1016/j.coph.2017.10.015">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2407 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5725238">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d11268e2417 class=n-a></a>Bouras EP, Camilleri M, Burton DD, <i> et al.</i>: Selective stimulation of colonic transit by the benzofuran 5HT<sub>4</sub> agonist, prucalopride, in healthy humans. <i>Gut.</i> 1999; <b>44</b>(5): 682–6. <a target=xrefwindow id=d11268e2431 href="http://www.ncbi.nlm.nih.gov/pubmed/10205205">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2435 href="http://dx.doi.org/10.1136/gut.44.5.682">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2438 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1727485">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d11268e2447 class=n-a></a>Miner PB Jr, Camilleri M, Burton D, <i> et al.</i>: Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study. <i>Neurogastroenterol Motil.</i> 2016; <b>28</b>(9): 1341–8. <a target=xrefwindow id=d11268e2458 href="http://www.ncbi.nlm.nih.gov/pubmed/27270968">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2461 href="http://dx.doi.org/10.1111/nmo.12832">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d11268e2470 class=n-a></a>Bouras EP, Camilleri M, Burton DD, <i> et al.</i>: Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. <i>Gastroenterology.</i> 2001; <b>120</b>(2): 354–60. <a target=xrefwindow id=d11268e2481 href="http://www.ncbi.nlm.nih.gov/pubmed/11159875">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2484 href="http://dx.doi.org/10.1053/gast.2001.21166">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1112206"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e2493 class=n-a></a>Camilleri M, Kerstens R, Rykx A, <i> et al.</i>: A placebo-controlled trial of prucalopride for severe chronic constipation. <i>N Engl J Med.</i> 2008; <b>358</b>(22): 2344–54. <a target=xrefwindow id=d11268e2504 href="http://www.ncbi.nlm.nih.gov/pubmed/18509121">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2507 href="http://dx.doi.org/10.1056/NEJMoa0800670">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1112206">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d11268e2520 class=n-a></a>Quigley EM, Vandeplassche L, Kerstens R, <i> et al.</i>: Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study. <i>Aliment Pharmacol Ther.</i> 2009; <b>29</b>(3): 315–28. <a target=xrefwindow id=d11268e2531 href="http://www.ncbi.nlm.nih.gov/pubmed/19035970">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2534 href="http://dx.doi.org/10.1111/j.1365-2036.2008.03884.x">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d11268e2543 class=n-a></a>Tack J, van Outryve M, Beyens G, <i> et al.</i>: Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. <i>Gut.</i> 2009; <b>58</b>(3): 357–65. <a target=xrefwindow id=d11268e2554 href="http://www.ncbi.nlm.nih.gov/pubmed/18987031">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2557 href="http://dx.doi.org/10.1136/gut.2008.162404">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d11268e2567 class=n-a></a>Tack J, Quigley E, Camilleri M, <i> et al.</i>: Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis. <i>United European Gastroenterol J.</i> 2013; <b>1</b>(1): 48–59. <a target=xrefwindow id=d11268e2578 href="http://www.ncbi.nlm.nih.gov/pubmed/24917940">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2581 href="http://dx.doi.org/10.1177/2050640612474651">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2585 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4040783">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725433886"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e2594 class=n-a></a>Yiannakou Y, Piessevaux H, Bouchoucha M, <i> et al.</i>: A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation. <i>Am J Gastroenterol.</i> 2015; <b>110</b>(5): 741–8. <a target=xrefwindow id=d11268e2605 href="http://www.ncbi.nlm.nih.gov/pubmed/25869393">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2608 href="http://dx.doi.org/10.1038/ajg.2015.115">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2612 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4424376">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725433886">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d11268e2625 class=n-a></a>Müller-Lissner S, Rykx A, Kerstens R, <i> et al.</i>: A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation. <i>Neurogastroenterol Motil.</i> 2010; <b>22</b>(9): 991–8, e255. <a target=xrefwindow id=d11268e2636 href="http://www.ncbi.nlm.nih.gov/pubmed/20529205">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2639 href="http://dx.doi.org/10.1111/j.1365-2982.2010.01533.x">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d11268e2648 class=n-a></a>Emmanuel AV, Kamm MA, Roy AJ, <i> et al.</i>: Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple <i>n</i> = 1 study. <i>Aliment Pharmacol Ther.</i> 2012; <b>35</b>(1): 48–55. <a target=xrefwindow id=d11268e2662 href="http://www.ncbi.nlm.nih.gov/pubmed/22061077">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2666 href="http://dx.doi.org/10.1111/j.1365-2036.2011.04907.x">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2669 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3298655">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d11268e2678 class=n-a></a>Sloots CE, Rykx A, Cools M, <i> et al.</i>: Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation. <i>Dig Dis Sci.</i> 2010; <b>55</b>(10): 2912–21. <a target=xrefwindow id=d11268e2689 href="http://www.ncbi.nlm.nih.gov/pubmed/20428949">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2692 href="http://dx.doi.org/10.1007/s10620-010-1229-y">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2696 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2943574">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d11268e2705 class=n-a></a>Krogh K, Jensen MB, Gandrup P, <i> et al.</i>: Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury. <i>Scand J Gastroenterol.</i> 2002; <b>37</b>(4): 431–6. <a target=xrefwindow id=d11268e2716 href="http://www.ncbi.nlm.nih.gov/pubmed/11989834">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2719 href="http://dx.doi.org/10.1080/003655202317316060">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d11268e2729 class=n-a></a>Camilleri M, Van Outryve MJ, Beyens G, <i> et al.</i>: Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. <i>Aliment Pharmacol Ther.</i> 2010; <b>32</b>(9): 1113–23. <a target=xrefwindow id=d11268e2740 href="http://www.ncbi.nlm.nih.gov/pubmed/21039673">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2743 href="http://dx.doi.org/10.1111/j.1365-2036.2010.04455.x">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d11268e2752 class=n-a></a>Piessevaux H, Corazziari E, Rey E, <i> et al.</i>: A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride. <i>Neurogastroenterol Motil.</i> 2015; <b>27</b>(6): 805–15. <a target=xrefwindow id=d11268e2763 href="http://www.ncbi.nlm.nih.gov/pubmed/25808103">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2766 href="http://dx.doi.org/10.1111/nmo.12553">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d11268e2775 class=n-a></a>Mendzelevski B, Ausma J, Chanter DO, <i> et al.</i>: Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study. <i>Br J Clin Pharmacol.</i> 2012; <b>73</b>(2): 203–9. <a target=xrefwindow id=d11268e2786 href="http://www.ncbi.nlm.nih.gov/pubmed/21848574">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2789 href="http://dx.doi.org/10.1111/j.1365-2125.2011.04088.x">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2793 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3269579">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d11268e2802 class=n-a></a>Camilleri M, Beyens G, Kerstens R, <i> et al.</i>: Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. <i>Neurogastroenterol Motil.</i> 2009; <b>21</b>(12): 1256–e117. <a target=xrefwindow id=d11268e2813 href="http://www.ncbi.nlm.nih.gov/pubmed/19751247">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2816 href="http://dx.doi.org/10.1111/j.1365-2982.2009.01398.x">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d11268e2825 class=n-a></a>Manini ML, Camilleri M, Goldberg M, <i> et al.</i>: Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. <i>Neurogastroenterol Motil.</i> 2010; <b>22</b>(1): 42–9, e7–8. <a target=xrefwindow id=d11268e2836 href="http://www.ncbi.nlm.nih.gov/pubmed/19691492">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2839 href="http://dx.doi.org/10.1111/j.1365-2982.2009.01378.x">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2843 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2905526">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734190239"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e2852 class=n-a></a>Bassotti G, Gambaccini D, Bellini M: Velusetrag for the treatment of chronic constipation. <i>Expert Opin Investig Drugs.</i> 2016; <b>25</b>(8): 985–90. <a target=xrefwindow id=d11268e2860 href="http://www.ncbi.nlm.nih.gov/pubmed/27269187">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2863 href="http://dx.doi.org/10.1080/13543784.2016.1195369">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734190239">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d11268e2877 class=n-a></a>Goldberg M, Li YP, Johanson JF, <i> et al.</i>: Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT<sub>4</sub> agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study. <i>Aliment Pharmacol Ther.</i> 2010; <b>32</b>(9): 1102–12. <a target=xrefwindow id=d11268e2891 href="http://www.ncbi.nlm.nih.gov/pubmed/21039672">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2895 href="http://dx.doi.org/10.1111/j.1365-2036.2010.04456.x">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d11268e2904 class=n-a></a>Camilleri M, Vazquez-Roque MI, Burton D, <i> et al.</i>: Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans. <i>Neurogastroenterol Motil.</i> 2007; <b>19</b>(1): 30–8. <a target=xrefwindow id=d11268e2915 href="http://www.ncbi.nlm.nih.gov/pubmed/17187586">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2918 href="http://dx.doi.org/10.1111/j.1365-2982.2006.00865.x">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d11268e2927 class=n-a></a>Renexxion Achieves Positive FDA Guidance for Phase 3-ready GI Drug Naronapride. 2016; [cited 2018 7th August]. <a target=xrefwindow id=d11268e2929 href="https://www.prnewswire.com/news-releases/renexxion-achieves-positive-fda-guidance-for-phase-3-ready-gi-drug-naronapride-300363946.html">Reference Source</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d11268e2938 class=n-a></a>Jeong EJ, Chung SY, Hong HN, <i> et al.</i>: The novel, potent and highly selective 5-HT<sub>4</sub> receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility. <i>Br J Pharmacol.</i> 2018; <b>175</b>(3): 485–500. <a target=xrefwindow id=d11268e2952 href="http://www.ncbi.nlm.nih.gov/pubmed/29139561">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2956 href="http://dx.doi.org/10.1111/bph.14096">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2959 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5773938">Free Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d11268e2968 class=n-a></a>Ahsan MK, Tchernychev B, Kessler MM, <i> et al.</i>: Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine. <i>Physiol Rep.</i> 2017; <b>5</b>(11): pii: e13299. <a target=xrefwindow id=d11268e2979 href="http://www.ncbi.nlm.nih.gov/pubmed/28592587">PubMed Abstract </a> | <a target=xrefwindow id=d11268e2982 href="http://dx.doi.org/10.14814/phy2.13299">Publisher Full Text </a> | <a target=xrefwindow id=d11268e2986 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5471438">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d11268e2995 class=n-a></a>Norimatsu Y, Moran AR, MacDonald KD: Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP<sub>4</sub>). <i>Biochem Biophys Res Commun.</i> 2012; <b>426</b>(3): 374–9. <a target=xrefwindow id=d11268e3006 href="http://www.ncbi.nlm.nih.gov/pubmed/22960173">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3009 href="http://dx.doi.org/10.1016/j.bbrc.2012.08.097">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3013 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3489164">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d11268e3023 class=n-a></a>Barish CF, Drossman D, Johanson JF, <i> et al.</i>: Efficacy and safety of lubiprostone in patients with chronic constipation. <i>Dig Dis Sci.</i> 2010; <b>55</b>(4): 1090–7. <a target=xrefwindow id=d11268e3034 href="http://www.ncbi.nlm.nih.gov/pubmed/20012484">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3037 href="http://dx.doi.org/10.1007/s10620-009-1068-x">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d11268e3046 class=n-a></a>Lembo AJ, Johanson JF, Parkman HP, <i> et al.</i>: Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation. <i>Dig Dis Sci.</i> 2011; <b>56</b>(9): 2639–45. <a target=xrefwindow id=d11268e3057 href="http://www.ncbi.nlm.nih.gov/pubmed/21769655">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3060 href="http://dx.doi.org/10.1007/s10620-011-1801-0">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3064 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3169778">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d11268e3073 class=n-a></a>Whitehead WE, Palsson OS, Gangarosa L, <i> et al.</i>: Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome. <i>Neurogastroenterol Motil.</i> 2011; <b>23</b>(10): 944–e400. <a target=xrefwindow id=d11268e3084 href="http://www.ncbi.nlm.nih.gov/pubmed/21914041">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3087 href="http://dx.doi.org/10.1111/j.1365-2982.2011.01776.x">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3091 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3184461">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d11268e3100 class=n-a></a>Christie J, Shroff S, Shahnavaz N, <i> et al.</i>: A Randomized, Double-Blind, Placebo-Controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients. <i>Am J Gastroenterol.</i> 2017; <b>112</b>(2): 356–64. <a target=xrefwindow id=d11268e3111 href="http://www.ncbi.nlm.nih.gov/pubmed/27922028">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3114 href="http://dx.doi.org/10.1038/ajg.2016.531">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733445561"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3123 class=n-a></a>Webster LR, Brewer RP, Lichtlen P, <i> et al.</i>: Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class. <i>Pain Med.</i> 2018; <b>19</b>(6): 1195–205. <a target=xrefwindow id=d11268e3134 href="http://www.ncbi.nlm.nih.gov/pubmed/29897589">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3137 href="http://dx.doi.org/10.1093/pm/pnx212">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733445561">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d11268e3150 class=n-a></a>Andresen V, Camilleri M, Busciglio IA, <i> et al.</i>: Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. <i>Gastroenterology.</i> 2007; <b>133</b>(3): 761–8. <a target=xrefwindow id=d11268e3161 href="http://www.ncbi.nlm.nih.gov/pubmed/17854590">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3164 href="http://dx.doi.org/10.1053/j.gastro.2007.06.067">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d11268e3174 class=n-a></a>Johnston JM, Kurtz CB, Drossman DA, <i> et al.</i>: Pilot study on the effect of linaclotide in patients with chronic constipation. <i>Am J Gastroenterol.</i> 2009; <b>104</b>(1): 125–32. <a target=xrefwindow id=d11268e3185 href="http://www.ncbi.nlm.nih.gov/pubmed/19098860">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3188 href="http://dx.doi.org/10.1038/ajg.2008.59">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4200969"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3197 class=n-a></a>Lembo AJ, Kurtz CB, MacDougall JE, <i> et al.</i>: Efficacy of linaclotide for patients with chronic constipation. <i>Gastroenterology.</i> 2010; <b>138</b>(3): 886–95.e1. <a target=xrefwindow id=d11268e3208 href="http://www.ncbi.nlm.nih.gov/pubmed/20045700">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3211 href="http://dx.doi.org/10.1053/j.gastro.2009.12.050">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4200969">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/12753956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3224 class=n-a></a>Lembo AJ, Schneier HA, Shiff SJ, <i> et al.</i>: Two randomized trials of linaclotide for chronic constipation. <i>N Engl J Med.</i> 2011; <b>365</b>(6): 527–36. <a target=xrefwindow id=d11268e3235 href="http://www.ncbi.nlm.nih.gov/pubmed/21830967">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3238 href="http://dx.doi.org/10.1056/NEJMoa1010863">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/12753956">F1000 Recommendation</a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d11268e3251 class=n-a></a>Bassotti G, Usai-Satta P, Bellini M: Linaclotide for the treatment of chronic constipation. <i>Expert Opin Pharmacother.</i> 2018; <b>19</b>(11): 1261–6. <a target=xrefwindow id=d11268e3259 href="http://www.ncbi.nlm.nih.gov/pubmed/29985664">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3262 href="http://dx.doi.org/10.1080/14656566.2018.1494728">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d11268e3271 class=n-a></a>Eutamene H, Bradesi S, Larauche M, <i> et al.</i>: Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. <i>Neurogastroenterol Motil.</i> 2010; <b>22</b>(3): 312–e84. <a target=xrefwindow id=d11268e3282 href="http://www.ncbi.nlm.nih.gov/pubmed/19706070">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3285 href="http://dx.doi.org/10.1111/j.1365-2982.2009.01385.x">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5205957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3294 class=n-a></a>Johnston JM, Kurtz CB, MacDougall JE, <i> et al.</i>: Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. <i>Gastroenterology.</i> 2010; <b>139</b>(6): 1877–1886.e2. <a target=xrefwindow id=d11268e3305 href="http://www.ncbi.nlm.nih.gov/pubmed/20801122">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3308 href="http://dx.doi.org/10.1053/j.gastro.2010.08.041">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5205957">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717958672"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3322 class=n-a></a>Chey WD, Lembo AJ, Lavins BJ, <i> et al.</i>: Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. <i>Am J Gastroenterol.</i> 2012; <b>107</b>(11): 1702–12. <a target=xrefwindow id=d11268e3333 href="http://www.ncbi.nlm.nih.gov/pubmed/22986437">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3336 href="http://dx.doi.org/10.1038/ajg.2012.254">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717958672">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d11268e3349 class=n-a></a>Al-Salama ZT, Syed YY: Plecanatide: First Global Approval. <i>Drugs.</i> 2017; <b>77</b>(5): 593–8. <a target=xrefwindow id=d11268e3357 href="http://www.ncbi.nlm.nih.gov/pubmed/28255961">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3360 href="http://dx.doi.org/10.1007/s40265-017-0718-0">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727289372"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3369 class=n-a></a>Miner PB Jr, Koltun WD, Wiener GJ, <i> et al.</i>: A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation. <i>Am J Gastroenterol.</i> 2017; <b>112</b>(4): 613–21. <a target=xrefwindow id=d11268e3380 href="http://www.ncbi.nlm.nih.gov/pubmed/28169285">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3383 href="http://dx.doi.org/10.1038/ajg.2016.611">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3387 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5415706">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727289372">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d11268e3400 class=n-a></a>DeMicco M, Barrow L, Hickey B, <i> et al.</i>: Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation. <i>Therap Adv Gastroenterol.</i> 2017; <b>10</b>(11): 837–51. <a target=xrefwindow id=d11268e3411 href="http://www.ncbi.nlm.nih.gov/pubmed/29147135">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3414 href="http://dx.doi.org/10.1177/1756283X17734697">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3418 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5673020">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d11268e3427 class=n-a></a>Barish CF, Griffin P: Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study. <i>Curr Med Res Opin.</i> 2018; <b>34</b>(4): 751–5. <a target=xrefwindow id=d11268e3435 href="http://www.ncbi.nlm.nih.gov/pubmed/29343131">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3438 href="http://dx.doi.org/10.1080/03007995.2018.1430024">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d11268e3447 class=n-a></a>Boulete IM, Thadi A, Beaufrand C, <i> et al.</i>: Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity <i>via</i> activation of guanylate cyclase-C in rat models. <i>World J Gastroenterol.</i> 2018; <b>24</b>(17): 1888–900. <a target=xrefwindow id=d11268e3461 href="http://www.ncbi.nlm.nih.gov/pubmed/29740204">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3465 href="http://dx.doi.org/10.3748/wjg.v24.i17.1888">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3468 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5937206">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d11268e3478 class=n-a></a>Brenner DM, Fogel R, Dorn SD, <i> et al.</i>: Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials. <i>Am J Gastroenterol.</i> 2018; <b>113</b>(5): 735–45. <a target=xrefwindow id=d11268e3489 href="http://www.ncbi.nlm.nih.gov/pubmed/29545635">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3492 href="http://dx.doi.org/10.1038/s41395-018-0026-7">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d11268e3501 class=n-a></a>Cil O, Phuan PW, Lee S, <i> et al.</i>: CFTR activator increases intestinal fluid secretion and normalizes stool output in a mouse model of constipation. <i>Cell Mol Gastroenterol Hepatol.</i> 2016; <b>2</b>(3): 317–27. <a target=xrefwindow id=d11268e3512 href="http://www.ncbi.nlm.nih.gov/pubmed/27127798">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3515 href="http://dx.doi.org/10.1016/j.jcmgh.2015.12.010">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3519 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4844355">Free Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d11268e3528 class=n-a></a>Son JH, Zhu JS, Phuan PW, <i> et al.</i>: High-Potency Phenylquinoxalinone Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activators. <i>J Med Chem.</i> 2017; <b>60</b>(6): 2401–10. <a target=xrefwindow id=d11268e3539 href="http://www.ncbi.nlm.nih.gov/pubmed/28230981">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3542 href="http://dx.doi.org/10.1021/acs.jmedchem.6b01759">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3546 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5463557">Free Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d11268e3555 class=n-a></a>Wong BS, Camilleri M: Elobixibat for the treatment of constipation. <i>Expert Opin Investig Drugs.</i> 2013; <b>22</b>(2): 277–84. <a target=xrefwindow id=d11268e3563 href="http://www.ncbi.nlm.nih.gov/pubmed/23215781">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3566 href="http://dx.doi.org/10.1517/13543784.2013.753056">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d11268e3575 class=n-a></a>Rudling M, Camilleri M, Graffner H, <i> et al.</i>: Specific inhibition of bile acid transport alters plasma lipids and GLP-1. <i>BMC Cardiovasc Disord.</i> 2015; <b>15</b>: 75. <a target=xrefwindow id=d11268e3586 href="http://www.ncbi.nlm.nih.gov/pubmed/26197999">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3589 href="http://dx.doi.org/10.1186/s12872-015-0070-9">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3593 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4511433">Free Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13356066"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3602 class=n-a></a>Chey WD, Camilleri M, Chang L, <i> et al.</i>: A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. <i>Am J Gastroenterol.</i> 2011; <b>106</b>(10): 1803–12. <a target=xrefwindow id=d11268e3613 href="http://www.ncbi.nlm.nih.gov/pubmed/21606974">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3616 href="http://dx.doi.org/10.1038/ajg.2011.162">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3620 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3188811">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13356066">F1000 Recommendation</a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733317762"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3634 class=n-a></a>Nakajima A, Seki M, Taniguchi S, <i> et al.</i>: Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. <i>Lancet Gastroenterol Hepatol.</i> 2018; <b>3</b>(8): 537–47. <a target=xrefwindow id=d11268e3645 href="http://www.ncbi.nlm.nih.gov/pubmed/29805116">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3648 href="http://dx.doi.org/10.1016/S2468-1253(18)30123-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733317762">F1000 Recommendation</a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d11268e3661 class=n-a></a>Rosenbaum DP, Yan A, Jacobs JW: Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers. <i>Clin Drug Investig.</i> 2018; <b>38</b>(4): 341–51. <a target=xrefwindow id=d11268e3669 href="http://www.ncbi.nlm.nih.gov/pubmed/29363027">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3672 href="http://dx.doi.org/10.1007/s40261-017-0614-0">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3675 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5856883">Free Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d11268e3684 class=n-a></a>Johansson SA, Knutsson M, Leonsson-Zachrisson M, <i> et al.</i>: Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study. <i>Clin Pharmacol Drug Dev.</i> 2017; <b>6</b>(5): 457–65. <a target=xrefwindow id=d11268e3695 href="http://www.ncbi.nlm.nih.gov/pubmed/28339149">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3698 href="http://dx.doi.org/10.1002/cpdd.341">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3702 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5599956">Free Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727355494"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3711 class=n-a></a>Chey WD, Lembo AJ, Rosenbaum DP: Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial. <i>Am J Gastroenterol.</i> 2017; <b>112</b>(5): 763–74. <a target=xrefwindow id=d11268e3719 href="http://www.ncbi.nlm.nih.gov/pubmed/28244495">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3722 href="http://dx.doi.org/10.1038/ajg.2017.41">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3725 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5418559">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727355494">F1000 Recommendation</a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d11268e3738 class=n-a></a>Block GA, Rosenbaum DP, Leonsson-Zachrisson M, <i> et al.</i>: Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis. <i>J Am Soc Nephrol.</i> 2017; <b>28</b>(6): 1933–42. <a target=xrefwindow id=d11268e3749 href="http://www.ncbi.nlm.nih.gov/pubmed/28159782">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3752 href="http://dx.doi.org/10.1681/ASN.2016080855">Publisher Full Text </a> | <a target=xrefwindow id=d11268e3756 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5461797">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d11268e3765 class=n-a></a>Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in Patients with IBS-C. 2017; [cited 2018 18th July]. <a target=xrefwindow id=d11268e3767 href="http://ir.ardelyx.com/news-releases/news-release-details/ardelyx-reports-successful-phase-3-t3mpo-1-trial-tenapanor">Reference Source</a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d11268e3777 class=n-a></a>Ardelyx's Pivotal Phase 3 Study of Tenapanor for IBS-C Hits Primary and All Secondary Endpoints to Support NDA Submission in 2018. 2017; [cited 2018 18th July]. <a target=xrefwindow id=d11268e3779 href="http://ir.ardelyx.com/news-releases/news-release-details/ardelyxs-pivotal-phase-3-study-tenapanor-ibs-c-hits-primary-and">Reference Source</a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717995431"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3788 class=n-a></a>Cinca R, Chera D, Gruss HJ, <i> et al.</i>: Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment. <i>Aliment Pharmacol Ther.</i> 2013; <b>37</b>(9): 876–86. <a target=xrefwindow id=d11268e3799 href="http://www.ncbi.nlm.nih.gov/pubmed/23480216">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3802 href="http://dx.doi.org/10.1111/apt.12278">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717995431">F1000 Recommendation</a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726416251"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11268e3815 class=n-a></a>Nelson AD, Camilleri M, Chirapongsathorn S, <i> et al.</i>: Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis. <i>Gut.</i> 2017; <b>66</b>(9): 1611–22. <a target=xrefwindow id=d11268e3826 href="http://www.ncbi.nlm.nih.gov/pubmed/27287486">PubMed Abstract </a> | <a target=xrefwindow id=d11268e3829 href="http://dx.doi.org/10.1136/gutjnl-2016-311835">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726416251">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 15 Oct 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1640&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1640&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA<br/> <sup>2</sup> Clinical Enteric Neuroscience Translational and Epidemiological Research Program and Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA<br/> <p> <div class=margin-bottom> David O. Prichard <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Adil E. Bharucha <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1640/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 15 Oct 2018, 7:1640 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.15900.1">https://doi.org/10.12688/f1000research.15900.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Prichard DO and Bharucha AE. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17359 data-id=15900 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15900.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1640/v1/pdf?article_uuid=2b847b95-548b-4c51-85bd-c9dd15c0f903" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.15900.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Prichard DO and Bharucha AE. Recent advances in understanding and managing chronic constipation [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1640 (<a href="https://doi.org/10.12688/f1000research.15900.1" target=_blank>https://doi.org/10.12688/f1000research.15900.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=15900 id=mobile-track-article-signin-15900 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15900?target=/articles/7-1640"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17359 /> <input name=articleId type=hidden value=15900 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Massimo Bellini</strong>, Gastrointestinal Unit, Department of Gastroenterology, University of Pisa, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Eamonn Quigley</strong>, Houston Methodist Hospital, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 15 Oct 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1640&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1640&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=35708-39298></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=40214-39299></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1640/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>15 Oct 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Massimo Bellini</strong>, Gastrointestinal Unit, Department of Gastroenterology, University of Pisa, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Eamonn Quigley</strong>, Houston Methodist Hospital, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1640&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1640/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding and managing...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1640/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1640/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1640/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Prichard DO and Bharucha AE');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1640/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1640",
            templates : {
                twitter : "Recent advances in understanding and managing chronic constipation. Prichard DO and Bharucha AE, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1640/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding and managing chronic constipation", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding and managing chronic constipation", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/15900/17359")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17359");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "39298": 0,
                           "39299": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "6bacf14d-9f8d-4915-87f7-21e7c7942c6f";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1640.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1640.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1640.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1640.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1640.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>